Literature DB >> 22564202

The moderating effects of group cognitive-behavioral therapy for depression among substance users.

Sarah B Hunter1, Katie Witkiewitz, Katherine E Watkins, Susan M Paddock, Kimberly A Hepner.   

Abstract

This study examined the prospective longitudinal relationship between changes in depressive symptoms on alcohol and/or drug (i.e., substance) use among addiction participants in treatment, and whether group cognitive-behavioral therapy for depression (GCBT-D) moderated the relationship. Using a quasi-experimental intent-to-treat design, 299 residential addiction treatment clients with depressive symptoms (Beck Depression Inventory-II, BDI-II scores > 17; Beck, Steer, & Brown, 1996) were assigned to either usual care (n = 159) or usual care plus a 16-session GCBT-D intervention (n = 140). Two follow-up interviews were conducted, one 3 months after the baseline interview corresponding to the end of the intervention, and then one 3 months later. Parallel-process growth modeling was used to examine changes in depressive symptoms and the associated changes in abstinence and negative consequences from substance use over time. Treatment group was included as a moderator of the association. Participants in the GCBT-D condition showed a greater increase in abstinence and greater decreases in depressive symptoms and negative consequences over time. There were significant interaction effects, such that the associations between depressive symptoms, negative consequences, and abstinence changes were larger in the usual-care condition than in the GCBT-D condition. The results suggest that the intervention may be effective by attenuating the association between depressive symptoms and substance use outcomes. These findings contribute to the emerging literature on the prospective longitudinal associations between depressive symptoms and substance use changes by being the first to examine them among a sample receiving GCBT-D in an addiction treatment setting. 2013 APA, all rights reserved

Entities:  

Mesh:

Year:  2012        PMID: 22564202      PMCID: PMC3416919          DOI: 10.1037/a0028158

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  44 in total

1.  The inventory of drug use consequences (InDUC): test-retest stability and sensitivity to detect change.

Authors:  J Scott Tonigan; William R Miller
Journal:  Psychol Addict Behav       Date:  2002-06

2.  Investigation of Mediational Processes Using Parallel Process Latent Growth Curve Modeling.

Authors:  Jeewon Cheong; David P Mackinnon; Siek Toon Khoo
Journal:  Struct Equ Modeling       Date:  2003-04-01       Impact factor: 6.125

3.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

4.  An examination of self-medication and rebound effects: Psychiatric symptomatology before and after alcohol or drug relapse.

Authors:  Kristin L Tomlinson; Susan R Tate; Kristen G Anderson; Denis M McCarthy; Sandra A Brown
Journal:  Addict Behav       Date:  2005-06-21       Impact factor: 3.913

5.  A descriptive analysis of minor depression.

Authors:  Mark Hyman Rapaport; Lewis L Judd; Pamela J Schettler; Kimberly Ann Yonkers; Michael E Thase; David J Kupfer; Ellen Frank; John M Plewes; Gary D Tollefson; A John Rush
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

6.  Depressive symptoms as a predictor of alcohol relapse after residential treatment programs for alcohol use disorder.

Authors:  Marius Suter; Werner Strik; Franz Moggi
Journal:  J Subst Abuse Treat       Date:  2011-05-05

Review 7.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

8.  Prevention of depression with primary care patients: a randomized controlled trial.

Authors:  R F Muñoz; Y W Ying; G Bernal; E J Pérez-Stable; J L Sorensen; W A Hargreaves; J Miranda; L S Miller
Journal:  Am J Community Psychol       Date:  1995-04

9.  Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.

Authors:  Robin E Clark; Mihail Samnaliev; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2009-01       Impact factor: 3.084

Review 10.  Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs).

Authors:  Kenneth R Conner; Martin Pinquart; Paul R Duberstein
Journal:  Addiction       Date:  2008-02-04       Impact factor: 6.526

View more
  2 in total

1.  Association between physical pain and alcohol treatment outcomes: The mediating role of negative affect.

Authors:  Katie Witkiewitz; Elizabeth McCallion; Kevin E Vowles; Megan Kirouac; Tessa Frohe; Stephen A Maisto; Ray Hodgson; Nick Heather
Journal:  J Consult Clin Psychol       Date:  2015-06-22

2.  A Multi-Site Cross-Sectional Study of Anxiety Symptoms and the Associated Factors Among Chinese Drug Users Undergoing Compulsory Detoxification Treatment.

Authors:  Xiaoshi Yang; Carrie Kovarik; Yuke Wang; Shenshui Yu
Journal:  Front Public Health       Date:  2021-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.